Mylan immune to outbreak of 'pollution' closure notices served to Indian firms
This article was originally published in Scrip
Executive Summary
Over a dozen pharmaceutical manufacturing units in the southern Indian state of Andhra Pradesh, including those of the local firms, Hetero Drugs and Aurobindo Pharma, and the multinational, Mylan, have been pulled up for allegedly violating pollution norms. But Mylan says its commercial operations are unaffected.